Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Role of MYC in B Cell Lymphomagenesis (CROSBI ID 240650)

Prilog u časopisu | pregledni rad (znanstveni) | međunarodna recenzija

Korać, Petra ; Dotlić, Snježana ; Matulić, Maja ; Zajc Petranović, Matea, Dominis, Mara Role of MYC in B Cell Lymphomagenesis // Genes, 8 (2017), 5; 115-115. doi: 10.3390/genes8040115

Podaci o odgovornosti

Korać, Petra ; Dotlić, Snježana ; Matulić, Maja ; Zajc Petranović, Matea, Dominis, Mara

engleski

Role of MYC in B Cell Lymphomagenesis

B cell lymphomas mainly arise from different developmental stages of B cells in germinal centers of secondary lymphoid tissue. There are a number of signaling pathways that affect the initiation and development of B cell lymphomagenesis. The functions of several key proteins that represent branching points of signaling networks are changed because of their aberrant expression, degradation, and/or accumulation, and those events determine the fate of the affected B cells. One of the most influential transcription factors, commonly associated with unfavorable prognosis for patients with B cell lymphoma, is nuclear phosphoprotein MYC. During B cell lymphomagenesis, oncogenic MYC variant is deregulated through various mechanisms, such as gene translocation, gene amplification, and epigenetic deregulation of its expression. Owing to alterations of downstream signaling cascades, MYC-overexpressing neoplastic B cells proliferate rapidly, avoid apoptosis, and become unresponsive to most conventional treatments. This review will summarize the roles of MYC in B cell development and oncogenesis, as well as its significance for current B cell lymphoma classification. We compared communication networks within transformed B cells in different lymphomas affected by overexpressed MYC and conducted a meta-analysis concerning the association of MYC with tumor prognosis in different patient populations.

B cell ; MYC ; lymphoma ; meta-analysis ; prognostic factor ; signaling pathways

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

8 (5)

2017.

115-115

objavljeno

2073-4425

10.3390/genes8040115

Povezanost rada

Biologija, Temeljne medicinske znanosti

Poveznice
Indeksiranost